The change of fractalkine in serum and pulmonary arterioles of hypoxic rat

Journal of Sichuan University (Medical Science)

Volumn 38, Issue 5, 2007, Pages 756-760

  Chen, Xiao Ju ^a   Cheng, De Yun ^a   Yang, Li ^a   Xia, Xiu Qiong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Fractalkine; Hypoxia; Pulmonary hypertension; Vascular remodeling

Indexed keywords

EID: 34948883428     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem, 1999; 274 (151): 10053-10058.
2. Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med, 1998; 188 (8): 1413-1419.
3. Goda S, Imai T, Yoshie O, et al. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J Immunol, 2000; 164 (8): 4313-4320.
4. Ruth JH, Volin MV, Haines GK 3rd, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvantinduced arthritis. Arthritis Rheum, 2001, 44(7): 1568-1581.
5. Greaves DR, Hakkinen T, Lucas AD, et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2001; 21(6): 923-929.
6. Raychaudhuri SP, Jiang WY, Farber EM. Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol, 2001; 144 (6): 1105-1113.
7. + cells in the prolonged mesangial proliferative glomerulonephritis. Kidney Int, 2002; 61 (6): 2044-2057.
8. Eisen E, Grappone C, DeFranco RMS, et al. Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol, 2002; 37 (1): 39-47.
9. Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005; 2(1): 20-22.
10. Stenmark KR, Davie NJ, Reeves JT, et al. Hypoxia, leukocytes and the pulmonary circulation. J Appl Physiol, 2005; 98 (2): 715-721.
11. Taraseviciene-Stewart L, Gera L, Hirth P, et al. A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model. Can J Physiol Pharmacol, 2002; 80 (4): 269-274.
12. Zhong X, Liang G, He Z. The roles of vascular endothellial growth factor and endothelin-1 on pulmonary vascular remodelling in rats with hypoxia-induced pulmonary hypertension. Zhonghua Nei Ke Za Zhi, 2001; 40 (8): 525-528.
13. Chinese source
14. Iioka Y, Tatsumi K, Sugito K, et al. Effects of insulin-like growth factor on weight gain in chronic hypoxic rats. J Cardiovasc Pharmacol, 2002; 39 (5): 636-642.
15. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature, 1997; 385 (6617): 640-644.
16. Yoneda O, Imai T, Goda S, et al. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol, 2000; 164 (8): 4055-4062.
17. Imaizumi T, Matsumiya T, Fujimoto K, et al. Interferon-γ stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells. Tohoku J Exp Med, 2000; 192 (2) : 127-139.
18. Foussat A, Coulomb-Lhermine A, Gosling J, et al. Fractalkine receptor expression by T-lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol, 2000; 30(1): 87-97.
19. Harrison JK, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA, 1998; 95 (18): 10896-10901.
20. Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell, 1997; 91 (4): 521-530.
21. Combadiere C, Salzwedel K, Smith ED, et al. Identification of CX3CR1. J Biol Chem, 1998; 273 (37): 23799-23804.
22. Papadopoulos EJ, Fitzhugh DJ, Tkaczyk C, et al. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol,2000; 30 (8): 2355-2361.
23. Fraticelli P, Sironi M, Bianchi G, et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest, 2001; 107 (9): 1173-1181.
24. Balabanian K, Foussat A, Dorfmüller P, et al. CX3C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med, 2002; 165 (10): 1419-1425.
25. Ruf A, Morgenstern E. Ultrastructural aspects of platelet adhesion on subendothelial structures. Semin Thromb Hemost, 1995; 21 (2): 119-122.